Damora Therapeutics Inc. Common Stock: A Biotechnology Company on the Rise
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) was the recipient of a significant growth in short interest in March. As of March 13th, there was short interest totaling 427,713 shares, a growth of 31.6% from the February 26th total of 325,076 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 220,622 shares, the short-interest ratio is currently 1.9 days.
Analyst Ratings and Price Targets
Several equities analysts have weighed in on the company. Wall Street Zen raised Damora Therapeutics, Inc. Common Stock from a “sell” rating to a “hold” rating in a research report on Saturday, December 6th. Lifesci Capital upgraded shares of Damora Therapeutics, Inc. Common Stock to a “strong-buy” rating in a research note on Monday, February 2nd. Leerink Partners initiated coverage on shares of Damora Therapeutics, Inc. Common Stock in a report on Wednesday, January 7th. They set an “outperform” rating and a $46.00 price objective for the company.
Hedge Fund Activity
A number of hedge funds have recently modified their holdings of DMRA. Ikarian Capital LLC bought a new position in shares of Damora Therapeutics, Inc. Common Stock during the fourth quarter valued at $6,574,000. Jain Global LLC acquired a new stake in shares of Damora Therapeutics, Inc. Common Stock during the 4th quarter worth about $2,774,000.
Company Overview
Damora Therapeutics, Inc. is a clinical‐stage biotechnology company developing small‐molecule therapies that target key pathways involved in fibrotic and malignant diseases. The company’s research focuses on inhibiting galectin‐3, an extracellular carbohydrate‐binding protein implicated in inflammation, fibrosis and tumor progression, as well as lysyl oxidase‐like 2 (LOXL2), an enzyme that crosslinks collagen and elastin in fibrotic tissue.
Investment Opportunities
For Indian investors looking to invest in the US stock market, US stock market investing can be a great way to diversify their portfolio. With the help of a stock broker, investors can buy and sell stocks on the NASDAQ and other US exchanges.